Viewing Study NCT02536794


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-02-25 @ 12:57 AM
Study NCT ID: NCT02536794
Status: COMPLETED
Last Update Posted: 2022-05-17
First Post: 2015-08-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer
Sponsor: Northwestern University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Estrogen Receptor Negative View
None Estrogen Receptor Positive View
None HER2/Neu Negative View
None Recurrent Breast Carcinoma View
None Stage IV Breast Cancer View
Keywords: